Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & Medscape

2 shared events · Importance 3 · Last updated Sep 02, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
32
Regulatory
United States — Food and Drug Administration: The FDA's July 27, 2026 briefing documents and July 29 advisory committee meeting triggered the stock collapse underlying the lawsuit, and its extension of the Deramiocel PDUFA date to November 22, 2026 keeps the review active.
Medscape: Medscape reported the advisory committee's 9-3 vote that available evidence did not support efficacy of Deramiocel, which triggered a further 36% stock decline.
Aug 10, 2026 · 267 articles
30
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Medscape: Reported on the advisory committee vote, providing details on the 9-3 decision.
Jul 27, 2026 · 305 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and Medscape interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.